IJERPH, Vol. 21, Pages 551: Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression
Conclusions: The ensuing recommendations were as follows: Recommendation 1: Depressive and anxiety disorders, as well as their pharmacological treatment, are not contraindications for breastfeeding. Recommendation 2: The Panel advocates for the continuation of medication that has demonstrated efficacy during pregnancy. If initiating an antidepressant during breastfeeding is necessary, drugs with a superior safety profile and substantial epidemiological data, such as SSRIs, should be favored and prescribed at the lowest effective dose. Recommendation 3: For the short-term alleviation of anxiety symptoms and sleep disturbances, the Panel determined that benzodiazepines can be administered during breastfeeding. Recommendation 4: The Panel advises against discontinuing opioid abuse treatment during breastfeeding. Recommendation 5: The Panel endorses collaboration among specialists (e.g., psychiatrists, pediatricians, toxicologists), promoting multidisciplinary care whenever feasible. Coordination with the general practitioner is also recommended.
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Georgios Eleftheriou Riccardo Zandonella Callegher Raffaella Butera Marco De Santis Anna Franca Cavaliere Sarah Vecchio Cecilia Lanzi Riccardo Davanzo Giovanna Mangili Emi Bondi Lorenzo Somaini Mariapina Gallo Matteo Balestrieri Guido Mannaioni Guglielmo Tags: Review Source Type: research
More News: Anxiety | Breastfed | Child Abuse | Depression | Environmental Health | Epidemiology | International Medicine & Public Health | Milk | Pediatrics | Postnatal Depression | Pregnancy | Primary Care | Psychiatry | Sleep Disorders | Sleep Medicine | Study | Substance Abuse | Toxicology | Women